Zynerba Shares Resume, Up 301%
Portfolio Pulse from Benzinga Newsdesk
Shares of Zynerba Pharmaceuticals, Inc. (ZYNE) have resumed trading and are up by 301%.
August 14, 2023 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zynerba Pharmaceuticals, Inc.'s stock price has significantly increased by 301%.
The news directly mentions Zynerba Pharmaceuticals, Inc. (ZYNE) and reports a significant increase in its stock price. This is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100